• FirefoxInstall the new Firefox »
  •  Dow Down 0.06% Nasdaq Up 0.42%

    Biogen Idec Inc. (BIIB)

    -NasdaqGS
    410.10 Up 1.16(0.28%) Feb 26, 4:00PM EST
    |After Hours : 409.21 Down 0.89 (0.22%) Feb 26, 4:41PM EST
    Add to Portfolio
    Prev Close:408.94
    Open:408.82
    Bid:408.00 x 3700
    Ask:N/A
    1y Target Est:419.83
    Beta:0.56
    Earnings Date:Apr 21 - Apr 27 (Est.)
    Day's Range:406.07 - 411.77
    52wk Range:0.80 - 411.77
    Volume:863,782
    Avg Vol (3m):1,791,490
    Market Cap:96.22B
    P/E (ttm):33.15
    EPS (ttm):12.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    BIIBUp 0.28%96.22B
    PFEDown 0.20%217.94B

    Key Statistics

    Forward P/E (1 yr):20.60
    P/S (ttm):9.89
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :16.96
    Quarterly EPS Est (Mar-15) :3.91
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):1.36

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback